Advances in pharmacological treatment and management of hyperhidrosis
Managing hyperhidrosis requires a nuanced, individualized strategy that balances symptom control, safety, patient preferences, and quality of life. Combination therapies and flexible treatment sequencing can reduce early reliance on invasive procedures. Despite therapeutic advances, widespread adoption is limited by heterogeneous guidelines, off-label use, and under-recognition of psychosocial impact. Future research should focus on prospective, large-cohort studies, standardized outcome measures, and development of selective, well-tolerated therapies. While a universal cure is unlikely, sustained symptom control and meaningful improvement in quality of life represent realistic objectives.
Authors
- Helena Gioacchini
- Anna Campanati (ORCID: https://orcid.org/0000-0002-3740-0839)
- Andrea Marani (ORCID: https://orcid.org/0000-0002-9826-6039)
- Agnese Rossi
Institutions
- Marche Polytechnic University (IT)
- Ospedale Infermi di Rimini (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
Publication Details
- Journal
- Expert Opinion on Pharmacotherapy
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1080/14656566.2026.2642213
- Primary Topic
- Sympathectomy and Hyperhidrosis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00